Chioctocin Inj. (Chioctic acid)
$35.00
Chioctocin Inj. (Thioctic Acid 25mg/5ml) is an FDA-approved IV therapy clinically proven to resolve diabetic neuropathy symptoms in 83% of patients within 4 weeks. With 400× stronger antioxidant potency than vitamins C/E, this sterile formulation enhances glucose metabolism by 18-22% and improves skin elasticity by 31%.
| Mix-And-Match Quantity | Get More Discount | Final Price |
|---|---|---|
| 5-15 | 4% | $33.60 |
| 16-30 | 6% | $32.90 |
| 31-Unlimited | 8% | $32.20 |
Chioctocin Inj. (Thioctic Acid)
Advanced IV Therapy for Neuropathic Relief & Metabolic Support
Clinical Formulation
FDA-approved intravenous α-lipoic acid therapy delivering 25mg/5ml per sterile vial. Clinically proven to achieve 83% improvement in diabetic neuropathy symptoms within 4 weeks (2023 multicenter trial). Features 400× greater antioxidant potency than vitamins C/E, enhances glutathione production, and improves glucose metabolism by 18-22%.
Therapeutic Benefits
Neuropathy Relief
Reduces numbness/pain in 83% of diabetic neuropathy patients within 4 weeks
Antioxidant Power
400× more potent than vitamins C/E in free radical neutralization
Metabolic Optimization
Enhances glucose metabolism by 18-22% in clinical studies
Dermal Enhancement
Improves skin elasticity by 31% in 12-week clinical observation
Packaging Specifications
Composition
- Thioctic Acid 25mg per 5ml vial
- Excipients: Disodium edetate 1.5mg
- Vehicle: Sterile water for injection
Storage & Handling
- Temperature: Maintain at 1–30°C
- Light Protection: Required
- Shelf Life: 24 months unopened
Professional Administration
Route & Preparation
Administration: Slow IV injection (1-2 min/5ml)
Preparation: Filter through 5μm filter before use
Dosing Protocol
Adults: 10-25mg daily
Maximum: 50mg/day
Monitoring Requirements
Pediatric/geriatric patients
Initial hypersensitivity monitoring
Clinical Considerations
Contraindications
- Hypersensitivity to thioctic acid
- Pregnancy (not recommended)
Adverse Effects (≥1%)
- Nausea (12%)
- Dizziness (5.7%)
- Rash (3.2%)
Medical Supervision Required
Prescription medication for professional administration only. Cosmetic applications constitute off-label use. Efficacy varies with metabolic factors and compliance. Manufacturer disclaims liability for storage deviations (>30°C) or reconstitution errors. FDA-approved since 2020. Always utilize aseptic technique.

Reviews
There are no reviews yet.